ImIquImod Cream 5%
Marketed by: Glenmark Generics Inc, USA, the US subsidiary of Glenmark Generics Limited (Mahwah, NJ)
Compared to: Aldara (Medicis Pharmaceutical Corp) Indication: The FDA approved Imiquimod Cream 5%, the generic equivalent to Medicis Pharmaceutical Corp’s Aldara. Imiquimod Cream 5% is indicated for the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults, and for the treatment of external genital and perianal warts/condyloma acuminate in patients 12 years and older.
Dosage Form: Cream: single-use packets each of which contains 250 mg of cream, equivalent to 12.5 mg of imiquimod
For More Information: http://us.glenmark-generics.com
Escitalopram Tablets USP
Marketed by: Teva Pharmaceuticals USA (Sellersville, PA)
Compared to: Lexapro (Forest Laboratories)
Indication: Teva announced the launch of Escitalopram Tablets USP, their generic version of Forest Laboratories’ Lexapro tablets. As the first company to file an abbreviated new drug application, Teva was granted 180-day exclusivity for this product. Escitalopram Tablets USP are indicated for the acute and maintenance treatment of major depressive disorder in adults and for the acute treatment of generalized anxiety disorder in adults.
Dosage Form: Tablets: 5, 10, and 20 mg
For More Information: www.tevausa.com
ZIprasIdone HydrochlorIde Capsules
Marketed by: Dr. Reddy’s Laboratories (Bridgewater, NJ)
Compared to: Geodon (Pfizer Inc)
Indication: Dr. Reddy’s Laboratories announced the launch of Ziprasidone Hydrochloride Capsules, a bioequivalent generic version of Pfizer Inc’s Geodon. Ziprasidone Hydrochloride Capsules are indicated for the treatment of schizophrenia, acute treatment as monotherapy of manic or mixed episodes associated with bipolar 1 disorder, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar 1 disorder. All dosages should be taken with food and are available in 60-count bottles.
Dosage Form: Capsules: 20, 40, 60, and 80 mg
For More Information: www.drreddys.com
Levetiracetam Oral SolutIon
Marketed by: Hi-Tech Pharmacal Co Inc (Amityville, NY)
Compared to: Keppra Oral Solution (UCB Inc)
Indication: The FDA approved Levetiracetam Oral Solution, an antiepileptic medication indicated to treat partial onset seizures in patients 16 years and older. Levetiracetam Oral Solution can be given with or without food. The dosing regimen depends on the indication, age group, dosage form (eg, tablets or oral solution), and renal function. The company plans to launch the product in May 2012.
Dosage Form: Oral solution: each mL contains 100 mg of levetiracetam
For More Information: www.hitechpharm.com